Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Diabetes Mellitus, Type 2/complications"" wg kryterium: Temat


Tytuł:
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
Autorzy:
Matthew C. Riddle
Christopher S Wilcox
Deepak L. Bhatt
Bertram Pitt
P. Gabriel Steg
Julia B. Lewis
Jeffrey M Testani
Marco Metra
Christopher P Cannon
Subodh Verma
Michael Szarek
Soloist-Whf Trial Investigators
Michel Komajda
Pablo Lapuerta
Lawrence A. Leiter
Adriaan A. Voors
Renato D Lopes
Lars H. Lund
Darren K. McGuire
Piotr Ponikowski
Pokaż więcej
Temat:
General Medicine
Internal medicine
medicine.medical_specialty
medicine
Multicenter study
Randomized controlled trial
law.invention
law
MEDLINE
Sotagliflozin
Heart failure
medicine.disease
Diabetes mellitus
In patient
Clinical trial
business.industry
business
CARDIOVASCULAR EVENT RATES
SGLT2 INHIBITOR
RISK
OUTCOMES
OUTPATIENTS
EMPAGLIFLOZIN
SAXAGLIPTIN
MORTALITY
MELLITUS
Acute Kidney Injury/chemically induced
Aged
Cardiovascular Diseases/epidemiology
Diabetes Mellitus, Type 2/complications
Double-Blind Method
Female
Glycosides/adverse effects
Heart Failure/complications
Hospitalization/statistics & numerical data
Humans
Hypotension/chemically induced
Male
Middle Aged
Sodium-Glucose Transporter 1/antagonists & inhibitors
Sodium-Glucose Transporter 2 Inhibitors/adverse effects
Źródło:
New England Journal of Medicine, 384(2), 117-128. MASSACHUSETTS MEDICAL SOC
SOLOIST-WHF Trial Investigators 2021, ' Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure ', The New England Journal of Medicine, vol. 384, no. 2, pp. 117-128 . https://doi.org/10.1056/NEJMoa2030183
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b07555c92ff2b3281b37cf5275a22dda
http://www.nejm.org/doi/pdf/10.1056/NEJMoa2030183
Tytuł:
Sotagliflozin in patients with diabetes and chronic kidney disease
Autorzy:
Bhatt, DL
Szarek, M
Pitt, B
Cannon, CP
Leiter, LA
McGuire, DK
Lewis, JB
Riddle, MC
Inzucchi, SE
Kosiborod, MN
Cherney, DZI
Dwyer, JP
Scirica, BM
Bailey, CJ
Díaz, R
Ray, KK
Udell, JA
Lopes, RD
Lapuerta, P
Steg, PG
SCORED Investigators
Pokaż więcej
Temat:
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
CARDIOVASCULAR EVENT RATES
SGLT2 INHIBITOR
HEART-FAILURE
RISK
OUTCOMES
OUTPATIENTS
EMPAGLIFLOZIN
SAXAGLIPTIN
MORTALITY
MELLITUS
Aged
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Diabetic Ketoacidosis
Diarrhea
Double-Blind Method
Female
Glycosides
Hospitalization
Humans
Male
Middle Aged
Mycoses
Renal Insufficiency, Chronic
Sodium-Glucose Transporter 1
Sodium-Glucose Transporter 2 Inhibitors
SCORED Investigators
11 Medical and Health Sciences
General Medicine
Clinical trial
Internal medicine
medicine.medical_specialty
medicine
business.industry
business
Randomized controlled trial
law.invention
law
Sotagliflozin
Diabetes mellitus
medicine.disease
MEDLINE
Kidney
medicine.anatomical_structure
In patient
Kidney disease
Cardiovascular Diseases/epidemiology
Diabetes Mellitus, Type 2/complications
Diabetic Ketoacidosis/chemically induced
Diarrhea/chemically induced
Glycosides/adverse effects
Hospitalization/statistics & numerical data
Mycoses/etiology
Renal Insufficiency, Chronic/complications
Sodium-Glucose Transporter 1/antagonists & inhibitors
Sodium-Glucose Transporter 2 Inhibitors/adverse effects
Źródło:
Bhatt, D L, Szarek, M, Pitt, B, Cannon, C P, Leiter, L A, McGuire, D K, Lewis, J B, Riddle, M C, Inzucchi, S E, Kosiborod, M N, Cherney, D Z I, Dwyer, J P, Scirica, B M, Bailey, C J, Díaz, R, Ray, K K, Udell, J A, Lopes, R D, Lapuerta, P, Steg, P G & SCORED Investigators 2021, ' Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease ', The New England Journal of Medicine, vol. 384, no. 2, pp. 129-139 . https://doi.org/10.1056/NEJMoa2030186
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e9705eeadc025b1e0478507d16cdaa4
https://publications.aston.ac.uk/id/eprint/42285/1/nejmoa2030186.pdf
Tytuł:
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
Autorzy:
C. David Sjöström
Robert D. Toto
Fan Fan Hou
Investigators
Anna Maria Langkilde
Peter Rossing
David C. Wheeler
Ricardo Correa-Rotter
Glenn M. Chertow
Bergur V. Stefánsson
Niels Jongs
Tom Greene
Dapa-Ckd Trial Committees
John J.V. McMurray
Hiddo J.L. Heerspink
Pokaż więcej
Temat:
Adult
Aged
Benzhydryl Compounds/adverse effects
Cardiovascular Diseases/chemically induced
Diabetes Mellitus, Type 2/complications
Diabetic Nephropathies/drug therapy
Double-Blind Method
Female
Glucosides/adverse effects
Heart Failure/chemically induced
Humans
Kidney/drug effects
Kidney Failure, Chronic/chemically induced
Male
Middle Aged
Renal Insufficiency, Chronic/complications
Treatment Outcome
Endocrinology
Endocrinology, Diabetes and Metabolism
Internal Medicine
Heart failure
medicine.disease
medicine
Diabetic nephropathy
Adverse effect
Dapagliflozin
chemistry.chemical_compound
chemistry
business.industry
business
Renal function
Diabetes mellitus
Internal medicine
medicine.medical_specialty
Kidney disease
Type 2 diabetes
Źródło:
Lancet Diabetes & Endocrinology, 9(1), 22-31. ELSEVIER SCIENCE INC
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a3a1159f26d848e4b231091b2729525
https://research.rug.nl/en/publications/effects-of-dapagliflozin-on-major-adverse-kidney-and-cardiovascular-events-in-patients-with-diabetic-and-nondiabetic-chronic-kidney-disease(92ee2074-5922-4044-aceb-cfcbddfff59c).html
Tytuł:
Transglutaminase 2 Conformation as a New Target to Treat Vascular Dysfunction in Aging and Diabetes
Autorzy:
Estéfano Pinilla
Pokaż więcej
Temat:
Pharmacology
Vascular function
Endothelial dysfunction
Transglutaminase 2
Transglutaminases/antagonists & inhibitors
Diabetes Mellitus, Type 2/complications
Aging
Farmacia
Źródło:
Pinilla, E 2020, Transglutaminase 2 Conformation as a New Target to Treat Vascular Dysfunction in Aging and Diabetes . Health, Aarhus University .
Aarhus University
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::270a52be60892db69b682c6d3b747ceb
https://pure.au.dk/portal/da/publications/transglutaminase-2-conformation-as-a-new-target-to-treat-vascular-dysfunction-in-aging-and-diabetes(c44262f2-d1da-4e89-9ce7-2d66ff748479).html
Tytuł:
Relative and absolute risk reductions in cardiovascular and kidney outcomes with canagliflozin across KDIGO risk categories: findings from the CANVAS Program
Autorzy:
Brendon L. Neuen
Jaime Blais
Vlado Perkovic
Bruce Neal
Qiang Li
Dick de Zeeuw
Meg Jardine
Kenneth W. Mahaffey
David C. Wheeler
Toshiaki Ohkuma
David R. Matthews
Greg Fulcher
Pokaż więcej
Temat:
CKD classification
Canagliflozin
KDIGO
SGLT2 inhibitor
adverse event
albuminuria
cardiovascular outcomes
chronic kidney disease (CKD)
eGFR slope
estimated glomerular filtration rate (eGFR)
kidney disease trajectory
kidney outcomes
renal function
risk stratification
urinary albumin-creatinine ratio (UACR)
Urology & Nephrology
1103 Clinical Sciences
1117 Public Health and Health Services
Albuminuria/diagnosis
Canagliflozin/administration & dosage
Cardiovascular Diseases/epidemiology
Creatinine/blood
Diabetes Mellitus, Type 2/complications
Female
Glomerular Filtration Rate/drug effects
Hospitalization/statistics & numerical data
Humans
Male
Mortality
Renal Insufficiency, Chronic/diagnosis
Risk Adjustment/methods
Risk Factors
Sodium-Glucose Transporter 2 Inhibitors/administration & dosage
Nephrology
Absolute risk reduction
Kidney disease
medicine.disease
medicine
Type 2 diabetes
Post-hoc analysis
Internal medicine
medicine.medical_specialty
Population
education.field_of_study
education
Placebo
business.industry
business
Albuminuria
medicine.symptom
medicine.drug
Źródło:
34.e1
American Journal of Kidney Diseases, 77(1), 23-34.e1. W B SAUNDERS CO-ELSEVIER INC
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7286628e3f2c922b7c17c1d7e3b8a4cf
http://hdl.handle.net/10044/1/84028
Tytuł:
Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery diseaseda persistent challenge in need of substantial improvement: A Report From ESC EORP EUROASPIRE V
Autorzy:
Dirk De Bacquer
David Wood
Lars Rydén
Guy De Backer
Giulia Ferrannini
Linda Mellbin
Kornelia Kotseva
Pokaż więcej
Temat:
Adolescent
Adult
Aged
Aged, 80 and over
Blood Glucose/analysis
Coronary Artery Disease/blood
Diabetes Mellitus, Type 2/complications
Europe/epidemiology
Female
Glucose Intolerance/complications
Glucose Metabolism Disorders/complications
Glucose Tolerance Test
Health Services Needs and Demand/organization & administration
Humans
Male
Mass Screening/methods
Middle Aged
Primary Prevention/methods
Program Evaluation
Quality Improvement
Risk Factors
Young Adult
Advanced and Specialised Nursing
Endocrinology, Diabetes and Metabolism
Internal Medicine
Observational study
Medicine
business.industry
business
Coronary artery disease
medicine.disease
Internal medicine
medicine.medical_specialty
Research design
Myocardial infarction
Impaired glucose tolerance
Glycemic
Diabetes mellitus
Type 2 diabetes
endocrine system diseases
nutritional and metabolic diseases
Źródło:
Diabetes care, 43(4), 726-733. American Diabetes Association Inc.
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::768c24849105c33dd6fc86b18924fea9
https://pure.amc.nl/en/publications/screening-for-glucose-perturbations-and-risk-factor-management-in-dysglycemic-patients-with-coronary-artery-diseaseda-persistent-challenge-in-need-of-substantial-improvement(977bb4c6-f8c4-4707-9d4c-7c3d14abc3f8).html
Tytuł:
Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes
Autorzy:
Philip Hasbak
Andreas Kjaer
Bernt Johan von Scholten
Emilie H. Zobel
Regitse Højgaard Christensen
Tine W. Hansen
Lene Holmvang
Christian Stevns Hansen
Peter Rossing
Signe Abitz Winther
Pokaż więcej
Temat:
Adipose Tissue/diagnostic imaging
Adiposity
Coronary Artery Disease/diagnostic imaging
Coronary Circulation
Diabetes Mellitus, Type 1/complications
Diabetes Mellitus, Type 2/complications
Humans
Microcirculation
Positron Emission Tomography Computed Tomography
Predictive Value of Tests
Retrospective Studies
Vascular Calcification/diagnostic imaging
Journal Article
Research Support, Non-U.S. Gov't
Cardiology and Cardiovascular Medicine
Endocrinology, Diabetes and Metabolism
Internal medicine
medicine.medical_specialty
medicine
Angiology
Diabetes mellitus
medicine.disease
Calcification
Type 2 diabetes
Cardiology
business.industry
business
Body mass index
Type 1 diabetes
Adipose tissue
Albuminuria
medicine.symptom
Cardiac adipose tissue
Epicardial adipose tissue
Pericardial adipose tissue
lcsh:Diseases of the circulatory (Cardiovascular) system
lcsh:RC666-701
Original Investigation
Myocardial flow reserve
Coronary artery calcium score
Cardiac sympathetic innervation
MIBG
Cardiac PET/CT
Źródło:
Zobel, E H, Christensen, R H, Winther, S A, Hasbak, P, Hansen, C S, von Scholten, B J, Holmvang, L, Kjaer, A, Rossing, P & Hansen, T W 2020, ' Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes ', Cardiovascular Diabetology, vol. 19, no. 1, 16 . https://doi.org/10.1186/s12933-020-0995-x
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-9 (2020)
Cardiovascular Diabetology
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c157f28fc20f31b0cc0d70a158f93d0
https://curis.ku.dk/ws/files/251787950/s12933_020_0995_x.pdf
Tytuł:
The Reduction of Visceral Adipose Tissue after Roux-en-Y Gastric Bypass Is more Pronounced in Patients with Impaired Glucose Metabolism
Autorzy:
Favre, Lucie
Marino, Laura
Roth, Aline
Acierno, James
Hans, Didier
Demartines, Nicolas
Pitteloud, Nelly
Suter, Michel
Collet, Tinh-Hai
Pokaż więcej
Temat:
Original Contributions
Bariatric surgery
Roux-en-Y gastric bypass
Visceral adipose tissue
Type 2 diabetes
Dual-energy X-ray absorptiometry (DXA)
Absorptiometry, Photon
Adult
Biomarkers/metabolism
Body Composition
Diabetes Mellitus, Type 2/complications
Diabetes Mellitus, Type 2/metabolism
Female
Follow-Up Studies
Gastric Bypass
Glucose/metabolism
Glucose Intolerance/metabolism
Humans
Insulin Resistance
Intra-Abdominal Fat/metabolism
Middle Aged
Obesity, Morbid/complications
Obesity, Morbid/metabolism
Obesity, Morbid/surgery
Prospective Studies
Risk Factors
Treatment Outcome
Weight Loss/physiology
Nutrition and Dietetics
Endocrinology, Diabetes and Metabolism
Surgery
Obesity
medicine.disease
medicine
Insulin resistance
Gastroenterology
medicine.medical_specialty
Internal medicine
Weight loss
medicine.symptom
Impaired glucose tolerance
Gastric bypass surgery
medicine.disease_cause
business.industry
business
Adipose tissue
Diabetes mellitus
nutritional and metabolic diseases
Źródło:
Obesity Surgery
Obesity surgery, vol. 28, no. 12, pp. 4006-4013
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc6c8c0a26e611762cb268bf62e20e13
http://europepmc.org/articles/PMC6223744
Tytuł:
‘I’ve put diabetes completely on the shelf till the mental stuff is in place’. How patients with doctor-assessed impaired self-care perceive disease, self-care, and support from general practitioners. A qualitative study
Autorzy:
Ann Dorrit Guassora
Mads Aage Toft Kristensen
Anne Beiter Arreskov
Bibi Hølge-Hazelton
Frans Boch Waldorff
Pokaż więcej
Temat:
Multimorbidity
chronic disease
patient acceptance of health care
general practice
self-care
continuity of patient care
lcsh:Public aspects of medicine
lcsh:RA1-1270
Journal Article
Mental Disorders/complications
Humans
Middle Aged
Patient-Centered Care
Male
Professional Role
Self Care/psychology
Chronic Disease/psychology
Aged, 80 and over
Adult
Female
Attitude
General Practitioners
Attention
Physician-Patient Relations
Diabetes Mellitus, Type 2/complications
Emotions
Quality of Life
Aged
Qualitative Research
Research Article
Public Health, Environmental and Occupational Health
Patient-centered care
Disease
General practice
Qualitative research
Nursing
Medicine
business.industry
business
Chronic disease
Diabetes mellitus
medicine.disease
Quality of life
Self care
Źródło:
Scandinavian Journal of Primary Health Care, Vol 36, Iss 3, Pp 342-351 (2018)
Kristensen, M A T, Guassora, A D, Arreskov, A B, WaldorfF, F B & Hølge-Hazelton, B 2018, ' 'I've put diabetes completely on the shelf till the mental stuff is in place'. How patients with doctor-assessed impaired self-care perceive disease, self-care, and support from general practitioners. A qualitative study ', Scandinavian Journal of Primary Health Care, vol. 36, no. 3, pp. 342-351 . https://doi.org/10.1080/02813432.2018.1487436
Kristensen, M A T, Guassora, A D, Arreskov, A B, Waldorff, F B & Hølge-Hazelton, B 2018, ' 'I've put diabetes completely on the shelf till the mental stuff is in place'. How patients with doctor-assessed impaired self-care perceive disease, self-care, and support from general practitioners : A qualitative study ', Scandinavian Journal of Primary Health Care, vol. 36, no. 3, pp. 342-351 . https://doi.org/10.1080/02813432.2018.1487436
Scandinavian Journal of Primary Health Care
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b66fc8ddce7fcb8ab07ac1e8418e33
https://doaj.org/article/9e5b8e3e838c42f8931c4f15fdc57895
Tytuł:
Asymptomatic bacteriuria and urinary tract infection in pregnant women with and without diabetes: Cohort study
Autorzy:
Schneeberger, Caroline
Erwich, Jan Jaap H. M.
van den Heuvel, Edwin R.
Mol, Ben W. J.
Ott, Alewijn
Geerlings, Suzanne E.
Pokaż więcej
Temat:
Asymptomatic bacteriuria
Urinary tract infection
Diabetes mellitus
Pregnancy
RISK
EXPOSURE
OUTCOMES
Prevalence
Prospective Studies
Follow-Up Studies
Humans
Bacteriuria/complications
Diabetes Mellitus, Type 1/complications
Pregnancy Trimester, First
Pregnancy Trimester, Third
Incidence
Asymptomatic Infections/epidemiology
Adult
Female
Netherlands/epidemiology
Pregnancy in Diabetics/microbiology
Prenatal Diagnosis
Risk Factors
Diabetes, Gestational/microbiology
Diabetes Mellitus, Type 2/complications
Pregnancy Complications, Infectious/diagnosis
Urinary Tract Infections/complications
Cohort Studies
Practice Guidelines as Topic
SDG 3 - Good Health and Well-being
Obstetrics and Gynaecology
Reproductive Medicine
Gestation
Obstetrics
medicine.medical_specialty
medicine
business.industry
business
medicine.disease
Urinary system
Urine
Cohort study
Relative risk
Small for gestational age
female genital diseases and pregnancy complications
Źródło:
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 222, 176-181. ELSEVIER SCIENCE BV
European Journal of Obstetrics & Gynecology and Reproductive Biology, 222, 176-181. Elsevier
European journal of obstetrics, gynecology, and reproductive biology, 222, 176-181. Elsevier Ireland Ltd
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5619a89c0e08feb7529a802098e6620
Tytuł:
Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)
Autorzy:
Jensen, Jesper
Omar, Massar
Kistorp, Caroline
Poulsen, Mikael Kjær
Tuxen, Christian
Gustafsson, Ida
Køber, Lars
Gustafsson, Finn
Fosbøl, Emil
Bruun, Niels Eske
Videbæk, Lars
Frederiksen, Peter Hartmund
Møller, Jacob Eifer
Schou, Morten
Pokaż więcej
Temat:
Study Protocol
Heart failure
SGLT2 inhibitors
Mechanism
Mode of action
NT-proBNP
Daily activity level
Cardiac function
Metabolic endpoints
Renal endpoints
Quality of life
Pharmacology (medical)
Medicine (miscellaneous)
Internal medicine
medicine.medical_specialty
medicine
Randomized controlled trial
law.invention
law
Ejection fraction
Cardiology
medicine.disease
Cardiac function curve
Placebo
business.industry
business
Clinical trial
Empagliflozin
Type 2 diabetes
lcsh:Medicine (General)
lcsh:R5-920
Benzhydryl Compounds/adverse effects
Diabetes Mellitus, Type 2/complications
Double-Blind Method
Glucosides/adverse effects
Heart Failure/drug therapy
Humans
Natriuretic Peptide, Brain/blood
Peptide Fragments/blood
Sodium-Glucose Transporter 2 Inhibitors/therapeutic use
Stroke Volume/drug effects
Journal Article
Randomized Controlled Trial
Źródło:
Trials
Jensen, J, Omar, M, Kistorp, C, Poulsen, M K, Tuxen, C, Gustafsson, I, Køber, L, Gustafsson, F, Fosbøl, E, Bruun, N E, Videbæk, L, Frederiksen, P H, Møller, J E & Schou, M 2019, ' Empagliflozin in heart failure patients with reduced ejection fraction : A randomized clinical trial (Empire HF) ', Trials, vol. 20, 374 . https://doi.org/10.1186/s13063-019-3474-5
Trials, Vol 20, Iss 1, Pp 1-8 (2019)
Jensen, J, Omar, M, Kistorp, C, Poulsen, M K, Tuxen, C, Gustafsson, I, Køber, L, Gustafsson, F, Fosbøl, E, Bruun, N E, Videbæk, L, Frederiksen, P H, Møller, J E & Schou, M 2019, ' Empagliflozin in heart failure patients with reduced ejection fraction : a randomized clinical trial (Empire HF) ', Trials, vol. 20, 374 . https://doi.org/10.1186/s13063-019-3474-5
Jensen, J, Omar, M, Kistorp, C, Poulsen, M K, Tuxen, C, Gustafsson, I, Køber, L, Gustafsson, F, Fosbøl, E, Bruun, N E, Videbæk, L, Frederiksen, P H, Møller, J E & Schou, M 2019, ' Empagliflozin in heart failure patients with reduced ejection fraction : a randomized clinical trial (Empire HF) ', Trials, vol. 20, no. 1, 374 . https://doi.org/10.1186/s13063-019-3474-5
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4c6304528bc49f4a5df6af158cfe1ff
http://europepmc.org/articles/PMC6588901
Tytuł:
Evaluation of anti-diabetic and anti-tumoral activities of bioactive compounds from Phoenix dactylifera L’s leaf: In vitro and in vivo approach
Autorzy:
Noureddine Drira
Mohamed Bouaziz
Naziha Marrakchi
Hafedh Mejdoub
M Chakroun
Mohamed Makni
Bassem Khemakhem
Hanen El Abed
Hazem Ben Mabrouk
Pokaż więcej
Temat:
Pharmacology
General Medicine
Diabetes mellitus
medicine.disease
medicine
Flavonoid
chemistry.chemical_classification
chemistry
IC50
MTT assay
Oral administration
In vivo
Postprandial
Biochemistry
Acarbose
medicine.drug
Phoenix dactylifera L.’s leaves
LC–MS/MS analysis
α-Glucosidase and α-Amylase
inhibitors
Antidiabetic activity
IGR-39 cancer cell lines
Cytotoxic activity
MESH: Animals
MESH: Antineoplastic Agents/pharmacology
MESH: Enzyme Assays
MESH: Humans
MESH: Hyperglycemia/complications
MESH: Hyperglycemia/drug therapy
MESH: Hypoglycemic Agents/pharmacology
MESH: Hypoglycemic Agents/therapeutic use
MESH: Male
MESH: Mice
MESH: Phoeniceae/chemistry
MESH: Phytochemicals/pharmacology
MESH: Antineoplastic Agents/therapeutic use
MESH: Phytochemicals/therapeutic use
MESH: Phytotherapy
MESH: Plant Extracts/pharmacology
MESH: Plant Extracts/therapeutic use
MESH: Plant Leaves/chemistry
MESH: Polyphenols/pharmacology
MESH: Polyphenols/therapeutic use
MESH: Postprandial Period
MESH: Tandem Mass Spectrometry
MESH: alpha-Amylases/metabolism
MESH: Cell Death/drug effects
MESH: alpha-Glucosidases/metabolism
MESH: Cell Line, Tumor
MESH: Chromatography, Liquid
MESH: Diabetes Mellitus, Experimental/complications
MESH: Diabetes Mellitus, Experimental/drug therapy
MESH: Diabetes Mellitus, Type 2/complications
MESH: Diabetes Mellitus, Type 2/drug therapy
[SDV]Life Sciences [q-bio]
[SDV.BV]Life Sciences [q-bio]/Vegetal Biology
[SDV.BV.PEP]Life Sciences [q-bio]/Vegetal Biology/Phytopathology and phytopharmacy
Źródło:
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, Elsevier Masson, 2016, 84, pp.415-422. ⟨10.1016/j.biopha.2016.09.062⟩
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637af2e2c971453a10bdd415909862d2
https://api.elsevier.com/content/article/PII:S0753332216311118?httpAccept=text/xml
Tytuł:
Patient Assessment of Family Function, Glycemic Control and Quality of Life in Adult Patients With Type 2 Diabetes and Incipient Complications
Autorzy:
Bennich, Birgitte B.
Munch, Lene
Egerod, Ingrid
Konradsen, Hanne
Ladelund, Steen
Knop, Filip K.
Vilsbøll, Tina
Røder, Michael
Overgaard, Dorthe
Pokaż więcej
Temat:
A1C (glycated hemoglobin level)
Brief FAM-III (Brief Family Assessment Measure)
family function
glycemic control
quality of life
type 2 diabetes
Journal Article
Body Mass Index
Life Style
Humans
Middle Aged
Self Report
Social Support
Cost of Illness
Blood Glucose
Male
Diabetes Mellitus, Type 2/complications
Female
Aged
Glycated Hemoglobin A/metabolism
Endocrinology
General Medicine
Endocrinology, Diabetes and Metabolism
Internal Medicine
Diabetes mellitus
medicine.disease
medicine
Quality of life
Glycemic
Confounding
Internal medicine
medicine.medical_specialty
Glycated hemoglobin
chemistry.chemical_compound
chemistry
Type 2 diabetes
Body mass index
Population
education.field_of_study
education
business.industry
business
Źródło:
Bennich, B B, Munch, L, Egerod, I, Konradsen, H, Ladelund, S, Knop, F K, Vilsbøll, T, Røder, M & Overgaard, D 2019, ' Patient Assessment of Family Function, Glycemic Control and Quality of Life in Adult Patients With Type 2 Diabetes and Incipient Complications ', Canadian Journal of Diabetes, vol. 43, no. 3, pp. 193-200 . https://doi.org/10.1016/j.jcjd.2018.09.002
BASE-Bielefeld Academic Search Engine
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09731b960203f36d9fdc6285cf4447aa
https://curis.ku.dk/portal/da/publications/patient-assessment-of-family-function-glycemic-control-and-quality-of-life-in-adult-patients-with-type-2-diabetes-and-incipient-complications(135f09b3-de12-45ba-b490-465d15a741a0).html

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz